Clinical Neurology and Neurosurgery
Volume 112, Issue 7 , Pages 572-574 , September 2010

HIV-related opsoclonus–myoclonus–ataxia syndrome: Report on two cases

  • Natlada Kanjanasut

      Affiliations

    • Chulalongkorn Comprehensive Movement Disorders Center, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand
    • ,
  • Kammant Phanthumchinda

      Affiliations

    • Chulalongkorn Comprehensive Movement Disorders Center, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand
    • ,
  • Roongroj Bhidayasiri

      Affiliations

    • Chulalongkorn Comprehensive Movement Disorders Center, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand
    • Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    • Corresponding Author InformationCorresponding author at: Chulalongkorn Comprehensive Movement Disorders Center, Chulalongkorn University Hospital, 1873 Rama 4 Road, Bangkok 10330, Thailand. Tel.: +66 2 256 4627; fax: +66 2 256 4630.

Received 7 August 2009 ,Revised 11 March 2010 ,Accepted 29 March 2010.

References 

  1. Caviness JN, Forsyth PA, Layton DD, McPhee TJ. The movement disorder of adult opsoclonus. Mov Disord. 1995;10:22–27
  2. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN, et al. B- and T-cell markers in opsoclonus–myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology. 2004;62:1526–1532
  3. Pranzatelli MR. The immunopharmacology of the opsoclonus–myoclonus syndrome. Clin Neuropharmacol. 1996;19:1–47
  4. Bartos A, Pitha J. Opsoclonus–myoclonus-dysequilibrium syndrome: cytological and immunological dynamics in the serial cerebrospinal fluid in two patients. J Neurol. 2003;250:1420–1425
  5. Blaes F, Fuhlhuber V, Korfei M, Tschernatsch M, Behnisch W, Rostasy K, et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol. 2005;58:313–317
  6. Verma A, Brozman B. Opsoclonus–myoclonus syndrome following Epstein-Barr virus infection. Neurology. 2002;58:1131–1132
  7. Sheth RD, Horwitz SJ, Aronoff S, Gingold M, Bodensteiner JB. Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. J Child Neurol. 1995;10:297–299
  8. Dassan P, Clarke C, Sharp DJ. A case of poststreptococcal opsoclonus–myoclonus syndrome. Mov Disord. 2007;22:1490–1491
  9. Candler PM, Dale RC, Griffin S, Church AJ, Wait R, Chapman MD, et al. Post-streptococcal opsoclonus–myoclonus syndrome associated with anti-neuroleukin antibodies. J Neurol Neurosurg Psychiatry. 2006;77:507–512
  10. Peter L, Jung J, Tilikete C, Ryvlin P, Mauguiere F. Opsoclonus–myoclonus as a manifestation of Lyme disease. J Neurol Neurosurg Psychiatry. 2006;77:1090–1091
  11. Kuban KC, Ephros MA, Freeman RL, Laffell LB, Bresnan MJ. Syndrome of opsoclonus–myoclonus caused by Coxsackie B3 infection. Ann Neurol. 1983;13:69–71
  12. Scott KM, Parker F, Heckmann JM. Opsoclonus–myoclonus syndrome and HIV infection. J Neurol Sci. 2009;
  13. Huruy K, Mulu A, Mengistu G, Shewa-Amare A, Akalu A, Kassu A, et al. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Jpn J Infect Dis. 2008;61:205–209
  14. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ. CSF B-cell expansion in opsoclonus–myoclonus syndrome: a biomarker of disease activity. Mov Disord. 2004;19:770–777
  15. Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus. Brain. 2001;124:437–443
  16. Pranzatelli MR, Tate ED, Wheeler A, Bass N, Gold AP, Griebel ML, et al. Screening for autoantibodies in children with opsoclonus–myoclonus–ataxia. Pediatr Neurol. 2002;27:384–387
  17. Bhidayasiri R, Somers JT, Kim JI, Ramat S, Nayak S, Bokil HS, et al. Ocular oscillations induced by shifts of the direction and depth of visual fixation. Ann Neurol. 2001;49:24–28
  18. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684–689
  19. van Toorn R, Rabie H, Warwick JM. Opsoclonus–myoclonus in an HIV-infected child on antiretroviral therapy—possible immune reconstitution inflammatory syndrome. Eur J Paediatr Neurol. 2005;9:423–426
  20. Ayarza A, Parisi V, Altclas J, Visconti D, Persi G, Rugilo CA, et al. Opsoclonus–myoclonus–ataxia syndrome and HIV seroconversion. J Neurol. 2009;256:1024–1025
  21. Garcia-Morales I, Porta-Etessam J, Saiz-Diaz R, Gomez-Escalonilla C, Galan L, Parrilla G, et al. Opsoclonus–myoclonus in a patient with AIDS: a good response to treatment with IV immunoglobulins. Rev Neurol. 1999;29:1346–1348
  22. Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: a review. Parkinsonism Relat Disord. 2004;10:323–334
  23. Maher J, Choudhri S, Halliday W, Power C, Nath A. AIDS dementia complex with generalized myoclonus. Mov Disord. 1997;12:593–597
  24. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871–1879

PII: S0303-8467(10)00097-1

doi: 10.1016/j.clineuro.2010.03.024

Clinical Neurology and Neurosurgery
Volume 112, Issue 7 , Pages 572-574 , September 2010

Article Tools

* Image Usage & Resolution